Landscapes / Companies
Glycyx Therapeutics not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 0 checked
Trials
1 active
8 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
TD-1211not checked |
— |
Phase 1/2 | 31 Aug 2027Phase 1/2 trial completes | ||
| Next date | 31 Aug 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M) | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021